Novel candidate targets of β-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas

Cancer Research

Volumn 63, Issue 11, 2003, Pages 2913-2922

  Schwartz, Donald R ^a   Wu, Rong ^a   Kardia, Sharon L R ^b   Levin, Albert M ^b   Huang, Chiang Ching ^a   Shedden, Kerby A ^a   Kuick, Rork ^a   Misek, David E ^a   Hanash, Samir M ^a   Taylor, Jeremy M G ^a   Reed, Heather ^a   Hendrix, Neali ^a   Zhai, Yali ^a   Fearon, Eric R ^a,b   Cho, Kathleen R ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR; WNT PROTEIN;

ARTICLE; ENDOMETRIOID CARCINOMA; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; OVARY ADENOCARCINOMA; PATHOGENESIS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; T LYMPHOCYTE; UNINDEXED SEQUENCE;

BETA CATENIN; BINDING SITES; CARCINOMA, ENDOMETRIOID; CONSENSUS SEQUENCE; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0037905677     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Schwartz, D. R., Kardia, S. L., Shedden, K. A., Kuick, R., Michailidis, G., Taylor, J. M., Misek, D. E., Wu, R., Zhai, Y., Darrah, D. M., Reed, H., Ellenson, L. H., Giordano, T. J., Fearon, E. R., Hanash, S. M., and Cho, K. R. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res., 62: 4722-4729, 2002.
2. Feeley, K. M., and Wells, M. Precursor lesions of ovarian epithelial malignancy. Histopathology, 38: 87-95, 2001.
3. Aunoble, B., Sanches, R., Didier, E., and Bignon, Y. J. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer. Int. J. Oncol., 16: 567-576, 2000.
4. Palacios, J., and Gamallo, C. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res., 58: 1344-1347, 1998.
5. Gamallo, C., Palacios, J., Moreno, G., Calvo de Mora, J., Suarez, A., and Armas, A. β-Catenin expression pattern in stage I and II ovarian carcinomas: relationship with β-catenin gene mutations, clinicopathological features, and clinical outcome. Am. J. Pathol., 155: 527-536, 1999.
6. Wright, K., Wilson, P., Morland, S., Campbell, I., Walsh, M., Hurst, T., Ward, B., Cummings, M., and Chenevix-Trench, G. β-Catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. Int. J. Cancer, 82: 625-629, 1999.
7. Sagae, S., Kobayashi, K., Nishioka, Y., Sugimura, M., Ishioka, S., Nagata, M., Terasawa, K., Tokino, T., and Kudo, R. Mutational analysis of β-catenin gene in Japanese ovarian carcinomas: frequent mutations in endometrioid carcinomas. Jpn. J. Cancer Res., 90: 510-515, 1999.
8. Saegusa, M., and Okayasu, I. Frequent nuclear β-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J. Pathol., 194: 59-67, 2001.
9. Wu, R., Zhai, Y., Fearon, E. R., and Cho, K. R. Diverse mechanisms of β-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res., 61: 8247-8255, 2001.
10. Cadigan, K. M., and Nusse, R. Wnt signaling: a common theme in animal development. Genes Dev., 11: 3286-3305, 1997.
11. Rubinfeld, B., Souza, B., Albert, I., Muller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., and Polakis, P. Association of the APC gene product with β-catenin. Science (Wash. DC), 262: 1731-1734, 1993.
12. Su, L-K., Vogelstein, B., and Kinzler, K. W. Association of the APC tumor suppressor protein with catenins. Science (Wash. DC), 262: 1734-1737, 1993.
13. Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B., and Polakis, P. Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3 β. Curr. Biol., 8: 573-581, 1998.
14. Munemitsu, S., Albert, I., Souza, B., and Polakis, P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA, 92: 3046-3050, 1995.
15. Yamamoto, H., Kishida, S., Uochi, T., Ikeda, S., Koyama, S., Asashima, M., and Kikuchi, A. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3β and β-catenin and inhibits axis formation of Xenopus embryos. Mol. Cell. Biol. 18: 2867-2875, 1998.
16. Nakamura, T., Hamada, F., Ishidate, T., Anai, K., Kawahara, K., Toyoshima, K., and Akiyama, T. Axin, an inhibitor of the Wnt signalling pathway, interacts with βcatenin, GSK-3β and APC and reduces the β-catenin level. Genes Cells, 3: 395-403, 1998.
17. Polakis, P. Wnt signaling and cancer. Genes Dev., 14: 1837-1851, 2000.
18. Peifer, M., and Polakis, P. Wnt signaling in oncogenesis and embryogenesis: a look outside the nucleus. Science (Wash. DC), 287: 1606-1609. 2000.
19. Rubinfeld, B., Robbins, P. D., El-Gamil, M., Albert, I., Porfiri, E., and Polakis, P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science (Wash. DC), 275: 1790-1792, 1997.
20. Koch, A., Denkhaus, D., Albrecht, S., Leuschner, I., von Schweinitz, D., and Pietsch, T. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene. Cancer Res., 59: 269-273, 1999.
21. Zurawel, R. H., Chiappa, S. A., Allen, C., and Raffel, C. Sporadic medulloblastomas contain oncogenic β-catenin mutations. Cancer Res., 58: 896-899, 1998.
22. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science (Wash. DC), 275: 1787-1790. 1997.
23. Voeller, H. J., Truica, C. I., and Gelmann, E. P. β-Catenin mutations in human prostate cancer. Cancer Res., 58: 2520-2523, 1998.
24. Chesire, D. R., Ewing, C. M., Sauvageot, J., Bova, G. S., and Isaacs, W. B. Detection and analysis of β-catenin mutations in prostate cancer. Prostate, 45: 323-334, 2000.
25. Fukuchi, T., Sakamoto, M., Tsuda, H., Maruyama, K., Nozawa, S., and Hirobashi, S. β-Catenin mutation in carcinoma of the uterine endometrium. Cancer Res., 58: 3526-3528, 1998.
26. Mirabelli-Primdahl, L., Gryfe, R., Kim, H., Millar, A., Luceri, C., Dale, D., Holowaty, E., Bapat, B., Gallinger, S., and Redston, M. β-Catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res., 59: 3346-3351, 1999.
27. Schlosshauer, P. W., Pirog, E. C., Levine, R. L., and Hedrick-Ellenson, L. Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma. Mod. Pathol., 13: 1066-1071, 2000.
28. Crawford, H. C., Fingleton, B. M., Rudolph-Owen, L. A., Goss, K. J., Rubinfeld, B., Polakis, P., and Matrisian, L. M. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene, 18: 2883-2891, 1999.
29. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R., and Ben-Ze'ev, A. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA, 96: 5522-5527, 1999.
30. Tetsu, O., and McCormick, F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond.), 398: 422-426, 1999.
31. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science (Wash. DC), 281: 1509-1512, 1998.
32. Carnac, G., Kodjabachian, L., Gurdon, J. B., and Lemaire, P. The homeobox gene Siamois is a target of the Wnt dorsalisation pathway and triggers organiser activity in the absence of mesoderm. Development (Cambr.), 122: 3055-3065, 1996.
33. Danielian, P. S., and McMahon, A. P. Engrailed-1 as a target of the Wnt-1 signalling pathway in vertebrate midbrain development. Nature (Lond.), 383: 332-334, 1996.
34. Fujita, M., Furukawa, Y., Tsunoda, T., Tanaka, T., Ogawa, M., and Nakamura, Y. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the β-catenin/T-cell factor complex, in colorectal carcinomas. Cancer Res., 61: 7722-7726, 2001.
35. Rockman, S. P., Currie, S. A., Ciavarella, M., Vincan, E., Dow, C., Thomas, R. J., and Phillips, W. A. 1d2 is a target of the β-catenin/TCF pathway in colon carcinoma. J. Biol. Chem., 276: 45113-45119, 2001.
36. Pennica, D., Swanson, T. A., Welsh, J. W., Roy, M. A., Lawrence, D. A., Lee, J., Brush, J., Taneyhill, L. A., Deuel, B., Lew, M., Watanabe, C., Cohen, R. L., Melhem, M. F., Finley, G. G., Quirke, P., Goddard, A. D., Hillan, K. J., Gurney, A. L., Botstein, D., and Levine, A. J. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA, 95: 14717-14722, 1998.
37. Zhai, Y., Wu, R., Schwartz, D. R., Darrah, D., Reed, H., Kolligs, F. T., Nieman, M. T., Fearon, E. R., and Cho, K. R. Role of β-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas. Am. J. Pathol., 160: 1229-1238, 2002.
38. Giordano, T. J., Shedden, K. A., Schwartz, D. R., Kuick, R., Taylor, J. M., Lee, N., Misek, D. E., Greenson, J. K., Kardia, S. L., Beer, D. G., Rennert, G., Cho, K. R., Gruber, S. B., Fearon, E. R., and Hanash, S. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am. J. Pathol., 159: 1231-1238, 2001.
39. Everitt, B. Cluster Analysis, 2nd ed. New York: Halsted, 1980.
40. Johnson, R., and Wichern, D. W. Principal components. In: Applied multivariate statistical analysis, 4th ed., pp. 458-513. Upper Saddle River, NJ: Prentice Hall, 1998.
41. Roose, J., and Clevers, H. TCF transcription factors: molecular switches in carcinogenesis. Biochim. Biophys. Acta, 1424: M23-M37, 1999.
42. Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., and Haussler, D. The human genome browser at UCSC. Genome Res., 12: 996-1006, 2002.
43. Kolligs, F. T., Hu, G., Dang, C. V., and Fearon, E. R. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol., 19: 5696-5706, 1999.
44. -/- colon carcinoma. Science (Wash. DC), 275: 1784-1789, 1998.
45. Kolligs, F. T., Nieman, M. T., Winer, I., Hu, G., Van Mater, D., Feng, Y., Smith, I. M., Wu, R., Zhai, Y., Cho, K. R., and Fearon, E. R. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation. Cancer Cell, 1: 145-155, 2002.
46. Kolligs, F. T., Kolligs, B., Hajra, K. M., Hu, G., Tani, M., Cho, K. R., and Fearon, E. R. γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin. Genes Dev., 14: 1319-1331, 2000.
47. Hinoi, T., Lucas, P. C., Kuick, R., Hanash, S., Cho, K. R., and Fearon, E. R. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology, 123: 1565-1577, 2002.
48. Kim, J. S., Crooks, H., Dracheva, T., Nishanian, T. G., Singh, B., Jen, J., and Waldman, T. Oncogenic β-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res., 62: 2744-2748, 2002.
49. Wielenga, V. J., Smits, R., Korinek, V., Smit, L., Kielman, M., Fodde, R., Clevers, H., and Pals, S. T. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am. J. Pathol., 154: 515-523, 1999.
50. Batlle, E., Henderson, J. T., Beghtel, H., van den Born, M. M., Sancho, E., Huls, G., Meeldijk, J., Robertson, J., van de Wetering, M., Pawson, T., and Clevers, H. β-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell, 111: 251-263, 2002.
51. Imai, K. S., Satoh, N., and Satou, Y. Early embryonic expression of FGF4/6/9 gene and its role in the induction of mesenchyme and notochord in Ciona savignyi embryos. Development (Cambr.), 129: 1729-1738, 2002.
52. Brabletz, T., Jung, A., Dag, S., Hlubek, F., and Kirchner, T. β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol., 155: 1033-1038, 1999.
53. Willert, J., Epping, M., Pollack, J. R., Brown, P. O., and Nusse, R. A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev. Biol., 2: 8, 2002.
54. Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., and Tlsty, T. D. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature (Lond.), 409: 633-637, 2001.
55. Jho, E. H., Zhang, T., Domon, C., Joo, C. K., Freund, J. N., and Costantini, F. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol., 22: 1172-1183, 2002.
56. Dubeau, L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol. Oncol., 72: 437-442, 1999.
57. Obata, K., Morland, S. J., Watson, R. H., Hitchcock, A., Chenevix-Trench, G., Thomas, E. J., and Campbell, I. G. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res., 58: 2095-2097, 1998.
58. Cuatrecasas, M., Erill, N., Musulen, E., Costa, I., Matias-Guiu, X., and Prat, J. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients. Cancer (Phila.), 82: 1088-1095, 1998.
59. Sharma, M., Chuang, W. W., and Sun, Z. Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3β inhibition and nuclear β-catenin accumulation. J. Biol. Chem., 277: 30935-30941, 2002.
60. Persad, S., Troussard, A. A., McPhee, T. R., Mulholland, D. J., and Dedhar, S. Tumor suppressor PTEN inhibits nuclear accumulation of β-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J. Cell Biol., 153: 1161-1174, 2001.
61. Bobek, L. A., Aguirre, A., and Levine, M. J. Human salivary cystatin S. Cloning, sequence analysis, hybridization in situ and immunocytochemistry. Biochem. J., 278: 627-635, 1991.
62. Parle-McDermott, A., McWilliam, P., Tighe, O., Dunican, D., and Croke, D. T. Serial analysis of gene expression identifies putative metastasis-associated transcripts in colon tumour cell lines. Br. J. Cancer, 83: 725-728, 2000.
63. Sotiropoulou, G., Anisowicz, A., and Sager, R. Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J. Biol. Chem., 272: 903-910, 1997.
64. Cox, J. L., Sexton, P. S., Green, T. J., and Darmani, N. A. Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin C. Melanoma Res., 9: 369-374, 1999.
65. Baron, A., DeCarlo, A., and Featherstone, J. Functional aspects of the human salivary cystatins in the oral environment. Oral Dis., 5: 234-240, 1999.
66. Kunimatsu, K., Yamamoto, K., Ichimaru, E., Kato, Y., and Kato, I. Cathepsins B, H and L activities in gingival crevicular fluid from chronic adult periodontitis patients and experimental gingivitis subjects. J. Periodontal Res., 25: 69-73. 1990.
67. Eley, B. M., and Cox, S. W. Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid: a comparison of levels before and after periodontal surgery in chronic periodontitis patients. J. Periodontol., 63: 412-417, 1992.
68. Dickinson, D. P. Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit. Rev. Oral Biol. Med., 13: 238-275, 2002.
69. Krepela, E. Cysteine proteinases in tumor cell growth and apoptosis. Neoplasma (Bratisl.), 48: 332-349, 2001.
70. Martucciello, G., Ceccherini, I., Lerone, M., and Jasonni, V. Pathogenesis of Hirschsprung's disease. J. Pediatr. Surg. 35: 1017-1025, 2000.
71. Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., and Masaki, T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. USA, 86: 2863-2867, 1989.